Artificial Labs secures £32.9m Series B funding led by CommerzVentures to accelerate international expansion.
The round was led by CommerzVentures with backing from Move Capital Fund I and existing investors to support global growth.
Artificial Labs provides digital broking and underwriting technology for the specialty and commercial insurance markets. The independent company helps brokers and carriers digitise complex workflows to optimise capacity deployment.
Artificial Labs has secured £32.9m in a Series B funding round led by CommerzVentures. The round also drew support from Move Capital Fund I alongside existing backers including Augmentum Fintech, 6 Degrees Capital, FOM, and TrueSight Ventures.
The capital will support the company as it prepares to double in size over the coming year and scale its operations internationally. Artificial Labs plans to launch its US expansion in 2026 while solidifying its footprint in the London Market.
The business builds software designed to help commercial and specialty insurance carriers and brokers modernise their trading and placement processes. The fresh funds provide additional stability and resources as the firm responds to rising demand from large market participants.
From the founder
"This round gives us the room to grow with confidence. The investment allows us to scale in a way that keeps pace with our clients. We have the teams, the technology, and the stability to support the largest brokers and carriers as they modernise how they operate."
David King
Co-Founder at Artificial Labs
Investor perspective
"We are thrilled to support Artificial as they extend their leadership globally."
Heiko Schwender
Managing Partner, CommerzVentures
Use of funds
- 01Grow the team
- 02Continue product development
- 03Expand into international markets
Investors
Heiko Schwender
CommerzVentures
Hervé Malausséna
Move Capital Fund I
Augmentum Fintech
6 Degrees Capital
FOM
TrueSight Ventures
Categories
About the company
Artificial Labs
Artificial Labs provides digital broking and underwriting technology for the specialty and commercial insurance markets.